Viewing Study NCT06174259



Ignite Creation Date: 2024-05-06 @ 7:54 PM
Last Modification Date: 2024-10-26 @ 3:16 PM
Study NCT ID: NCT06174259
Status: RECRUITING
Last Update Posted: 2024-02-01
First Post: 2023-12-08

Brief Title: Influence of Intermittent Fasting on Locally Advanced Breast Cancer Patients
Sponsor: Menoufia University
Organization: Menoufia University

Study Overview

Official Title: Influence of Intermittent Fasting on Locally Advanced Breast Cancer Patients a Prospective Randomized Controlled Trial
Status: RECRUITING
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Breast cancer is the most common cancer type among women in Egypt and world Preclinical studies show fasting reduces growth factors and modulates nutrient sensing systems protecting normal cells against chemotherapy However cancer cells are not protected due to Differential Stress Resistance DSR making them more vulnerable to chemotherapeutics This study aims to evaluate intermittent fasting impact on neoadjuvant chemotherapy in breast cancer patients
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None